Applied DNA Sciences Inc EBITDA Margin 2010-2024 | APDN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Applied DNA Sciences Inc (APDN) over the last 10 years. The current EBITDA margin for Applied DNA Sciences Inc as of March 31, 2024 is .
| Applied DNA Sciences Inc EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-03-31 |
$0.01B |
$-0.01B |
-216.67% |
| 2023-12-31 |
$0.01B |
$-0.01B |
-133.33% |
| 2023-09-30 |
$0.01B |
$-0.01B |
-76.92% |
| 2023-06-30 |
$0.02B |
$-0.01B |
-62.50% |
| 2023-03-31 |
$0.02B |
$-0.01B |
-58.82% |
| 2022-12-31 |
$0.02B |
$-0.01B |
-52.63% |
| 2022-09-30 |
$0.02B |
$-0.01B |
-72.22% |
| 2022-06-30 |
$0.02B |
$-0.01B |
-76.47% |
| 2022-03-31 |
$0.02B |
$-0.01B |
-86.67% |
| 2021-12-31 |
$0.01B |
$-0.01B |
-108.33% |
| 2021-09-30 |
$0.01B |
$-0.01B |
-120.00% |
| 2021-06-30 |
$0.01B |
$-0.01B |
-171.43% |
| 2021-03-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2020-12-31 |
$0.00B |
$-0.01B |
-433.33% |
| 2020-09-30 |
$0.00B |
$-0.01B |
-650.00% |
| 2020-06-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2020-03-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2019-12-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2019-09-30 |
$0.01B |
$-0.01B |
-150.00% |
| 2019-06-30 |
$0.01B |
$-0.01B |
-200.00% |
| 2019-03-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2018-12-31 |
$0.00B |
$-0.01B |
-275.00% |
| 2018-09-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2018-06-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2018-03-31 |
$0.01B |
$-0.01B |
-200.00% |
| 2017-12-31 |
$0.01B |
$-0.01B |
-220.00% |
| 2017-09-30 |
$0.01B |
$-0.01B |
-240.00% |
| 2017-06-30 |
$0.01B |
$-0.01B |
-183.33% |
| 2017-03-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2016-12-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2016-09-30 |
$0.01B |
$-0.01B |
-220.00% |
| 2016-06-30 |
$0.01B |
$-0.01B |
-128.57% |
| 2016-03-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-77.78% |
| 2015-09-30 |
$0.01B |
$-0.01B |
-88.89% |
| 2015-06-30 |
$0.01B |
$-0.01B |
-183.33% |
| 2015-03-31 |
$0.01B |
$-0.01B |
-220.00% |
| 2014-12-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2014-09-30 |
$0.00B |
$-0.01B |
-300.00% |
| 2014-06-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2014-03-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2013-12-31 |
$0.00B |
$-0.01B |
-400.00% |
| 2013-09-30 |
$0.00B |
$-0.01B |
-500.00% |
| 2013-06-30 |
$0.00B |
$-0.01B |
-1000.00% |
| 2013-03-31 |
$0.00B |
$-0.01B |
-800.00% |
| 2012-12-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2012-09-30 |
$0.00B |
$-0.01B |
-166.67% |
| 2012-06-30 |
$0.00B |
$-0.01B |
-200.00% |
| 2012-03-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2011-12-31 |
$0.00B |
$-0.01B |
-500.00% |
| 2011-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2011-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2011-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2010-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2010-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2009-12-31 |
$0.00B |
$-0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.000B |
$0.013B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
